JanOne Inc (JAN)

[againstallodds]

Geotraq pretty much dead on twitter & Facebook

Is it still in operation ?

Most of JAN value in assets is related to Geotraq.

Geotraq never declared ANY SALES...

[againstallodds]

10K late: disagreement with accounting firm over assets?

[againstallodds]

JAN is a cash burning machine

Constantly losing money

Intangible assets way overvalued in the books

Headed towards pre R/S values

Isaac bad CEO

[againstallodds]

Headed towards pre R/S values ??!

[againstallodds]

Intangible assets: 54% of total assets !!!

And they should probably ALL BE WRITTEN-OFF

[Principian]

And let's not forget about those Inflated Intangible Assets too. They should at least have written off that bogus Patent.

[againstallodds]

JAN needs Geotraq asset's in its Balance Sheet

Even if we all know the value of those assets is helium filled

[Principian]

That is correct on those Chips from Sequans being old.

As well not a single filing yet via the FCC for Geotraq being authorized to use them in a design.

The market for IoT Modules as well as Asset Trackers is very crowded. Why buy a product from Geotraq when you can get a complete solution now from major cellular providers like Verizon for less than $7.00.

[againstallodds]

Geotraq old chips inventory now worth zero?

They have been keeping these chips inventory for a while now without ever making a sale with them

They probably are obsolete by now

[canada tommy]

Velmer You horafacicious knikki!!

[snakess]

There are catalysts that can easily proper JAN higher.
1. The company has mentioned that they want to sell the recycle biz. If that happens the cash horde would be huge and could support the pain drug!
The stock would make a huge move if the sell the division for $30-40 million.
2. Geotrac- The Preferred situation is a "money on your back", but i believe they will either spin it off, sell it or joint venture it. All three possible event will make the stock jump.
3. Earnings that is 10k due out in 1 months. if numbers are good the stock pops.
4.Additional management added concerning the pain side of the company again will pop the stock.
5. You can call it a poor man's IPO to raise money by backing a division into a fully reporting NASDAQ company,but this management is very proactive towards shareholder and that is very positive.
Some have mentioned hype- don't see it! They put a press release out explaining the near term future- A gun was not put at anyone's head!
Pain is a huge issue when 192 people die everyday from overdoses of pain killers.
With only 1.9 million shares outstanding u must be in it before the next news release because if you are not then you will miss the move

[againstallodds]

Did JAN pay manufacturing cash or in shares?

Or is it only an agreement but not a commitment

Eager to see how much money JAN lost in the next 10Q

[Principian]

JAN/ARCI since I have been following it from 2017 has had similar patterns. I briefly bought into the Stock as I am more into Technology Investments but then I realized after doing some DD things were not to my liking.

The old saying about "Buying on the Hype and Selling on the News" rings true.

A good chunk of this stock is held by Insiders as well there is a real shady Preferred Stock Conversion hanging in the background in which the Issacs along with a Crony of theirs will be a "Pill that is hard to Swallow" on outside investors. These PRs are an attempt to walk up the price. They failed at the same strategy when doing this via their Geotraq entity.

They'd announce something, retail investors would jump and then when the reality of the matter got closer Attention the stock would fall right back to were it was before it even lower. Go back and look at the spikes over the last 3 years and look at the 8Ks during the same time. It went under the NASDAQ Price Threshold half a dozen times and they had to finally do a Reverse Split to buy them time. Now this while changing to a BioTech is also now suspect IMHO.

Buyer Beware...

[Principian]

this picking a Mfg is odd at this stage in the game. no details of what this would mean as far as how much this is going to cost. This company is a "Contract MFG". This move would be more inline at a later time. The Stage 2 Trials is for the most part is on formulating the drug and then having that go thru a wider human sample set than what was done in Stage 1. you are trying to figure out what dosage levels work and then kind of pick the "Sweet Spot". Its all about the uptake of the drug in the humans and then uping the dosages or lowering them. And from all research I have done so far, this ends up being by far the most costly of the stages of any drug research.

I've been trying to understand a little more on how various drug related companies go thru these Trials and Processes.

So far it is a little strange that all these people coming on board are all from the one company that has been doing the initial research. And what this kind of smells like is they are using JAN as a means to raise money via the Stock Market where they could not do this via their existing entity without going thru all the basic requirements to sell stock to the public. Finance People tend to call this a "Poorman's IPO".

ARCI is then Pumping up the Stock on all these PR Moves.

Then there is GEOTRAQ hanging onto JAN/ARIC like a Dead Weight burning thru their Working Capital with NO Sales.

When are they going to announce that it is time to "Cut Bait" on Geotraq?

[snakess]

so sick of the clay crap about the chart. Now because the jan ran fast and drop fast he decides it was a pump and dump. Show me the pump? they put out a presser release that described the plan of action so investor jumped and then decided it was many months away and decided to sell! If it was pumped then investors pumped and decided that the news was fair not excellent. At least this cmpy put out press releases regularly vs the fact that there are so many cmpy's that do little for shareholders.

[ClayTrader]

Did Guidance Marketing, LLC receive compensation ?

That question is answered on the opening slide of the video, down at the bottom.

[ClayTrader]

The disclaimer is up to date.

[againstallodds]

Huber, where is yous disclaimer for Jan?

Were you not paid $375 by Isaac ?

Please update us

[againstallodds]

Did Guidance Marketing, LLC receive compensation ?

In exchange of working for Jan?

Is Clay Huber still the sole agent for Guidance Marketing?

Tony, how much and how did you compensate Hubet?

[ClayTrader]

* * $JAN Video Chart 02-06-2020 * *

Link to Video - click here to watch the technical chart video

[againstallodds]

TV1001SR Not approved. Manufacture before it is approved???

Long stretch ahead of outflows before generating any revenues...

Eager to see next filings.

[crudeoil24]

CEO > Tony Issac > $$$$$ > Las Vegas !!!!!

[crudeoil24]

JanOne Announces MAnufacturing Agreement For TV1001SR In Peripheral Artery Disease
9:03 am ET February 6, 2020 (Benzinga) Print
JanOne Inc. (NASDAQ:JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease (PAD). PAD affects over 8.5 million people in the United States and there are currently no direct treatments for PAD on the market today. Research Market Future (MRFR) values the PAD market at $3.47 billion in the United States by 2023.1"

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[Principian]

I wouldn't be surprised if JanOne dumps GEOTRAQ in 2020.

I too am interested in seeing the upcoming 10-K. With Geotraq Bleeding Money with no sales for going on 3 years, sooner or later it will be time to "Cut Bait".

There comes a time, when reality sets in and if you have two Bleeders, you have to make a choice and its clear ARCI is putting its "Eggs" on shifting to BioTech.

They are Rolling the Dice, but it is clear that BioTech seems to be an easier route for Hyping the Stock Price. "Buy on the Hype - Sell on the News"...

[againstallodds]

Why have they gagged the transfer agent???

[againstallodds]

Eager to see consolidated losses next Q

Geotraq losing money

Pharma development is always a money pit

[againstallodds]

What’s the budget to vomplete phase 2A ?

How much mony is Jan committed to spend to complete the clinical trials?

Where will this money come from?

[againstallodds]

Clinical trials are all expenses with no revenues

And the chances of revenues are very slim.

Il original results were that encouraging, there would never have been a pause in said clinical trials.

Jon bought another storyline to try to keep the sp up.

Geotrak is going absolutely nowhere.

[Principian]

Phase 2B Clinical Trials. Invesyors should familiarize yourselves with the Approval processes.

https://en.m.wikipedia.org/wiki/Phases_of_clinical_research

I find it interesting on the statistics being presented. According to the above link approximately 18% of the Drugs make it out of the Phase 2 Trial and approximately only 50% make it past Phase 3.

It would be worth while to understand in this case who actually is taking on the monetary risks. The above link also indicates these phases are the most costly to go thru. Phase 3 being the most costly and Time Consuming.

An investor would have to consider the timeframes for a return on their investments.

It also will be interesting to understand exactly what this Chief Scientist is getting out of this from ARCI/JAN.

Question I have is he still appears to be the CEO of Theravasc so why get into bed with a company such as ARCI/JAN. There is no announcements he is stepping down. So to me this is only a move to build Marketing Creditability.

I dont know enough about the Biotech Industry, but something just like Geotraq here doesn't smell right.

[Principian]

Pump & Dump... kind of funny, the Hype hit before regular trading hours and then fell off fast.

I wonder how many people took the time to actually read the Deal that was struck it is available as part of the SEC Filing. Weird thing is all the key financial details are Redacted except for a $250K Initial License Fee along with an estimate of $6.5 Million.

it appears to me the direction of this deal is more in attempting to resell the same License to possible companies.

The PAD Drug/Treatment is still undergoing FDA Trials. This is a High Risk Move.

In essence the Deal makes ARCI/JAN into a "Middleman". The Deal also had a number of Milestones that were Redacted so it isnt exactly indicative of what ARCI has to accomplish as well as how much capital and timeframes. If milestones are not met, the Deal could Default and all money and fees are Non-Refundable.

[420man]

Grabbed a few 3.50's for the reversal over the next few days. GL

[ClayTrader]

* * $JAN Video Chart 11-25-2019 * *

Link to Video - click here to watch the technical chart video

[TheFinalCD]

https://finviz.com/quote.ashx?t=JAN

wow look at the history of exaggerated spikes

pops followed by drops

lower lows

looks like dilution

micro share structure

big swings

both ways

[crudeoil24]

Na,na,na,na, hey,hey, goodbye!

[crudeoil24]

You're not kidding; C'mon Jan!

[420man]

Nice grab...waiting for a potential strong dip before the rest of the market takes notice. GL

Any second now and CHK gonna explode ;)

[VMB-1]

~Got some 5.30's..1M Float..LETS HALT THIS MOFO!

[420man]

Could hit $10 on open! Give me some quick 5's before open?!?

[420man]

10 min double bagger... Grab some on the pull back

[420man]

Weeeeee!

[DJ Ponder]

LMFAO
SUCH A DEAL.

On August 18, 2017, the Company acquired all of the assets and capital stock of GeoTraq by way of merger, the result of which GeoTraq became a wholly-owned subsidiary of the Company.
The final fair value of the single identifiable intangible asset acquired in the GeoTraq acquisition is a U.S. patent USPTO reference No. 10,182,402 titled “Locator Device with Low Power Consumption” together with the assignment of intellectual property that included historical know-how, designs and related manufacturing procedures was $26,097 which included the deferred income tax liability associated with the intangible asset. Total consideration paid in connection with the acquisition of GeoTraq consisted of $200 in cash, unsecured promissory notes bearing interest at the annual rate of 1.29% maturing on August 18, 2018 in the aggregate principal of $800, and 288,588 shares (exact number) of Series A-1 Preferred Stock (as defined below) with a final fair value of $14,963. See Note 17 – Series A-1 Preferred Stock. In connection with the acquisition, an additional intangible asset amount was recorded in the amount of $10,134 and an offsetting deferred tax liability recorded of the same amount, $10,134, to reflect the future tax liability attributable to the GeoTraq asset acquired. There were no other assets acquired or liabilities assumed.
At the time of the acquisition of GeoTraq, GeoTraq had no business operations, one intangible asset and historical know-how and designs. GeoTraq is in the development stage.


GOOD GRIEF

[Principian]

No revenue for Geotraq and I have yet to see any filings at the FCC. Without those Certifications there absolutely will be no sales. They also have not applied for an FCC Exception, which this would be an appropriate route to go down, but has a drawback of then pushing Product Certifications onto the Companies that would integrate this Cellular Module into their own Products. To get the Exception, they basically would Piggy-Back onto the Certifications done by their main Chip Supplier - Sequans. I suspect they more than likely are getting into issues of dealing with Batteries and Antennas. There also is a fair amount of S/W and APIs that would need to be Designed. This amounts to a Buy vs Build Scenario. Its hard to tell exactly how much Geotraq possibly is spending either on Employees or on any Outsourcing.

From what some of the Geotraq Website is stating on Certifications is they are targeting Verizon, AT&T & T-Mobile. Therefore, this means this solution would only be usable in the United States. Hardly a World-wide Solution as they are Advertising. They'll need Certifications in each country they intend to have the product operating. Also it appears any mention of Gregg Sullivan's Patent are fully Scrubbed. Being in the Telecom Industry, they are a "Day Late and a Dollar Short". The Mobile IoT Market is massively saturated from the Established Players. In fact, you can buy the same Sequans Chip in an established product Direct from Verizon for as little as $6.50.

Ask yourself, if you are a Corporate Buyer or even a Product Design Engineer, are you going to go with a Company such as Geotraq that has a NON-Standard Form Factor Product and has NO Track Record or are you going to go with a more Established Player??

The more time goes by the worse this Uphill Battle will become to win any kind of Market Share. Real Customers in dealing with Telecom Products are highly "Conservative", so winning over an "Early Adopter" in this Market is now going to become very unlikely as Companies have already deployed and tested out the Products from these Existing Vendors. It will take more than a Hot Blonde Marketing Chick generating Hype to make this a Success.

As well, this BioTech Move. This is by far sets off so many Red Flags for Shareholders. With a Negative Working Capital and already having Operational Expense Issues, entering a new market is crazy especially considering they hired a Celebrity Influencer with his own issues in Judgement and Behavior are concerned.

Meanwhile, here is a quick rundown on some Financial Metrics of JAN/ARCI.

Working Capital: -$2.319 Million
Book Value: $16.704 Million
Adjusted Book Value: -$1.489 Million (Book Value - Intangible Assets)

It will take me a bit to look at all the other Financials I am tracking.

Stay Tuned...

Intangible Ratio: 54%

[againstallodds]

10Q out https://www.otcmarkets.com/filing/html?id=13749623&guid=NZUvUefWOf6yvth

Still no revenue for Geotraq...

[Principian]

Especially that $10 Million Deferred Tax Asset as part of the Geotraq purchase.

There have been ZERO Sales of any Geotraq products or service.

[againstallodds]

Disagreements on Geotraq assets value perhaps?

[againstallodds]

WARNING : ACCOUNTING FIRM RESIGNED

This never is a good news...

[againstallodds]

He owns a new scam nves…

check the whois on this website.

[Principian]

Kind of funny if you read the latest Proxy Statement, you will see Gregg Sullivan mentioned in regards to his Preferred Shares. It referred to him as "Last Known Address".

I knew this loser was going to skip town. The address they had put him in an Apartment off the Vegas Strip. Personally, he always looked like he was Stoned or Hung Over. Dude always seemed to have red glassy eyes and wrinkled clothes. Sad.

Anyone know where he is hiding out?

Today, this stock pushed a new Low of $2.00. It closed at $2.26. Pre-Reverse-Split of 5:1 this puts the shares at $0.452.

[againstallodds]

They should add to agenda: Isaac destitution...

The guy doesn't know how to create value obviously

Should recycle in crap shoot only...

[Principian]

Approaching a new 52 week Low. let's see if JAN/ARCI falls below $2.25